Column for DNA/RNA separation and purification "Presep® DNA/RNA"
Presep® DNA/RNA columns are solid-phase extraction columns suitable for the separation and purification of nucleic acids. Type A columns are mini-columns filled with a silica-based separating agent in a barrel-shaped syringe, which can be used for solid-phase extraction in reversed-phase systems.
Features
- Achieves a high sample load
- Enables a sample load 3 to 5 times higher than commercially available pretreatment columns
- Excellent deprotection efficiency
- Enables purification with a high level of purity and high recovery rate
Product Appearance
Specification
| No. | Product Name | Packing Materials | Syringe Size | Purification amount |
|---|---|---|---|---|
| 1. | Presep® DNA/RNA Type A (85 mg / 1 mL) | Silica gel | 5.5 φ × 57 mm | 0.2-0.5 μmol |
| 2. | Presep® DNA/RNA Type A (255 mg / 3 mL) | Silica gel | 9.0 φ × 63 mm | 1-1.5 μmol |
| 3. | Presep® DNA/RNA Type A (1.0 g / 15 mL) | Silica gel | 15 φ × 87 mm | 4-6 μmol |
| 4. | Presep® DNA/RNA Type A (1.7 mg / 25 mL) | Silica gel | 21 φ × 85 mm | 6-10 μmol |
| 5. | Presep® DNA/RNA Type A (5.1 mg / 70 mL) | Silica gel | 27 φ × 134 mm | 20-30 μmol |
Precautions for Use
Presep® DNA/RNA should be used in the aspiration mode where the exit side of the column is depressurized and aspirated. An aspiration manifold is useful for handling multiple samples.
Solid-phase extraction conditions (recommended)
1. Presep® DNA/RNA Type A (85 mg / 1 mL)
| Steps | Materials | Amount Used |
|---|---|---|
| Conditioning | Acetonitrile | 1 mL |
| 100 mg/mL NaCl aq. | 1 mL × 2 | |
| Sample Load | Sample solution 0.5 mL + 100 mg/mL NaCl aq. 0.5 mL | 1mL |
| Washing 1 | Acetonitrile/100 mg/mL NaCl aq.=5/95(v/v) | 1 mL × 2 |
| Deprotection | 2% DCA*1 aq. (DCA/Water=2/98(v/v)) | 1 mL |
| Washing 2 | RNase Free Water | 1 mL × 2 |
| Elution | 0.5% NH4OH in Acetonitrile/Water=50/50(v/v)*2 | 1 mL |
2. Presep® DNA/RNA Type A (255 mg / 3 mL)
| Steps | Materials | Amount Used |
|---|---|---|
| Conditioning | Acetonitrile | 3 mL |
| 100 mg/mL NaCl aq. | 3 mL × 2 | |
| Sample Load | Sample solution 1 mL + 100 mg/mL NaCl aq. 1 mL | 2 mL |
| Washing 1 | Acetonitrile/100 mg/mL NaCl aq.=5/95(v/v) | 3 mL × 2 |
| Deprotection | 2% DCA*1 aq. (DCA/Water=2/98(v/v)) | 3 mL |
| Washing 2 | RNase Free Water | 3 mL × 2 |
| Elution | 0.5% NH4OH in Acetonitrile/Water=50/50(v/v)*2 | 3 mL |
3. Presep® DNA/RNA Type A (1.0 g / 15 mL)
| Steps | Materials | Amount Used |
|---|---|---|
| Conditioning | Acetonitrile | 12 mL |
| 100 mg/mL NaCl aq. | 12 mL × 2 | |
| Sample Load | Sample solution 5 mL + 100 mg/mL NaCl aq. 5 mL | 10 mL |
| Washing 1 | Acetonitrile/100 mg/mL NaCl aq.=5/95(v/v) | 12 mL × 2 |
| Deprotection | 2% DCA*1 aq. (DCA/Water=2/98(v/v)) | 12 mL |
| Washing 2 | RNase Free Water | 12 mL × 2 |
| Elution | 0.5% NH4OH in Acetonitrile/Water=50/50(v/v)*2 | 12 mL |
4. Presep® DNA/RNA Type A (1.7 g / 25 mL)
| Steps | Materials | Amount Used |
|---|---|---|
| Conditioning | Acetonitrile | 20 mL |
| 100 mg/mL NaCl aq. | 20 mL × 2 | |
| Sample Load | Sample solution 10 mL + 100 mg/mL NaCl aq. 10 mL | 20 mL |
| Washing 1 | Acetonitrile/100 mg/mL NaCl aq.=5/95(v/v) | 20 mL × 2 |
| Deprotection | 2% DCA*1 aq. (DCA/Water=2/98(v/v)) | 20 mL |
| Washing 2 | RNase Free Water | 20 mL × 2 |
| Elution | 0.5% NH4OH in Acetonitrile/Water=50/50(v/v)*2 | 20 mL |
5. Presep® DNA/RNA Type A (5.1 mg / 70 mL)
| Steps | Materials | Amount Used |
|---|---|---|
| Conditioning | Acetonitrile | 60 mL |
| 100 mg/mL NaCl aq. | 60 mL × 2 | |
| Sample Load | Sample solution 20 mL + 100 mg/mL NaCl aq. 20 mL | 40 mL |
| Washing 1 | Acetonitrile/100 mg/mL NaCl aq.=5/95(v/v) | 60 mL × 2 |
| Deprotection | 2% DCA*1 aq. (DCA/Water=2/98(v/v)) | 60 mL |
| Washing 2 | RNase Free Water | 60 mL × 2 |
| Elution | 0.5% NH4OH in Acetonitrile/Water=50/50(v/v)*2 | 60 mL |
*2 Add 50 µL of 28% ammonium hydroxide per 10 mL of 50% acetonitrile in water.
Comparison of separation capacity
1. Recovery of oligonucleotide
Sample of Cartridge Column
| Wako (Presep® DNA/RNA Type A) |
Competitor A | Competitor B | Competitor C | |
|---|---|---|---|---|
| Particle Support | Silica gel | Silica gel | Polymer | Polymer |
Sample of Oligonucleotide
| Sample Name | Length | Linkage Structure |
|---|---|---|
| Sample 1 | 14 mer | PO |
| Sample 2 | 21 mer | PO |
| Sample 3 | 21 mer | PS |
| Sample 4 | 50 mer | PO |
Cartridge Column vs Recovery of oligonucleotide [%]
achieves high recovery.
Wako ≒ B > A > C
- Oligonucleotide samples were purified using the protocol recommended by each company.
- Oligonucleotide concentration was measured with an absorbance meter.
- Recovery was calculated as "oligonucleotide concentration in the eluate/oligonucleotide concentration before loading".
2. Allowable load of oligonucleotide
Sample Load vs Recovery of oligonucleotide [%]
a high support retention capacity.
When the ratio of the load of oligonucleotide to support was increased to 9.7, Wako’s product maintained a recovery rate of 75% or higher in contrast to competitor products (A, B, and C) that had a recovery rate of less than 65%.
Product List
- Open All
- Close All
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.